Alzamend Neuro Inc (ALZN) — Financial Flexibility Index
Alzamend Neuro Inc (ALZN) has a Financial Flexibility Index of -0.93x as of January 2026. Free cash flow of $-1.74 Million (operating CF $-1.74 Million minus capex $0.00) represents -1% of total liabilities ($1.86 Million). Check Alzamend Neuro Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alzamend Neuro Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Alzamend Neuro Inc across 10 annual periods. See Alzamend Neuro Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Alzamend Neuro Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Alzamend Neuro Inc. For the full company profile including market capitalisation, see ALZN stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -9.87x | $-6.27 Million | $-6.57 Million | $634.76K | ▼ -292.2% |
| 2024 | -2.52x | $-8.12 Million | $-8.27 Million | $3.23 Million | ▲ +19.0% |
| 2023 | -3.11x | $-8.92 Million | $-8.92 Million | $2.87 Million | ▲ +44.3% |
| 2022 | -5.59x | $-6.51 Million | $-6.61 Million | $1.16 Million | ▼ -92.9% |
| 2021 | -2.90x | $-2.61 Million | $-2.71 Million | $899.64K | ▼ -28.3% |
| 2020 | -2.26x | $-2.24 Million | $-2.35 Million | $992.31K | ▼ -184.6% |
| 2019 | -0.79x | $-938.74K | $-1.05 Million | $1.18 Million | ▲ +96.3% |
| 2018 | -21.21x | $-2.05 Million | $-2.05 Million | $96.72K | ▼ -973.9% |
| 2017 | -1.98x | $-1.42 Million | $-1.42 Million | $717.22K | ▼ -228.1% |
| 2016 | -0.60x | $-18.49K | $-18.49K | $30.72K | — |